Biotin is a cofactor for five carboxylase enzymes critical to metabolism: pyruvate carboxylase, acetyl-CoA carboxylases (1 and 2), propionyl-CoA carboxylase, and 3-methylcrotonyl-CoA carboxylase. True deficiency is rare in developed countries, biotin is widely distributed in foods and produced by gut bacteria.
Populations at risk: pregnant women (accelerated biotin catabolism), individuals on long-term anticonvulsants (carbamazepine, phenytoin), chronic alcohol users, and people consuming large amounts of raw egg whites (avidin binds biotin).
Accelerate biotin metabolism → depletion risk
HIGH-DOSE BIOTIN INTERFERES WITH STREPTAVIDIN-BIOTIN IMMUNOASSAYS, causes FALSE troponin results (may miss heart attack) and FALSE thyroid results
This is biotin's most important safety concern. Biotin at doses ≥1,000mcg interferes with streptavidin-biotin immunoassays used in most clinical laboratories:
The FDA issued a safety communication in November 2017 about this interference. Patients taking high-dose biotin should stop supplementation 72 hours before any blood work.
Not Prohibited
Reference identifiers on this page are being re-verified against PubMed. Some may not yet link to the paper named beside them.
, Colombo VE et al. Treatment of brittle fingernails with biotin.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated: April 2026
Not medical advice. Based on published clinical research and systematic reviews.